Parsons Corporation Free Cash Flow 2017–2025
Parsons Corporation reported $410.41M of free cash flow for fiscal 2025. That was 13.5% lower than fiscal 2024. Compared with fiscal 2020, the change was +60.9%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $410.41M | -13.5% |
| FY 2024 | $474.39M | +29.2% |
| FY 2023 | $367.30M | +77.5% |
| FY 2022 | $206.93M | +12.2% |
| FY 2021 | $184.47M | -27.7% |
| FY 2020 | $255.13M | +67.1% |
| FY 2019 | $152.64M | -40.2% |
| FY 2018 | $255.35M | +7.7% |
| FY 2017 | $237.09M | — |
Source: Parsons Corporation SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open PSN 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Parsons Corporation reported $410.41M of free cash flow for fiscal 2025. That was 13.5% lower than fiscal 2024. Compared with fiscal 2020, the change was +60.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Parsons Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeParsons Corporation — frequently asked questions
What is Parsons Corporation's free cash flow?
Parsons Corporation (PSN) reported free cash flow of $410.41M for fiscal year 2025, per its SEC filings.
How has Parsons Corporation's free cash flow changed over time?
Between fiscal 2017 and 2025, PSN's free cash flow grew at roughly 7.1% per year (compound annual rate), from $237.09M to $410.41M.
Where does this data come from?
Figures are computed from Parsons Corporation's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.